Catalyst Wire Dossier Catalyst Wire Dossier

VV261 Tablets

VV261 · Vigonvita Life Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VV261 Tablets, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers [Phase 1]

See pricing